膀胱癌：ESMO诊断、治疗及随访临床实践指南 - Suppr

Suppr

超能文献

Bladder cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.

作者信息

Moschini M, Gandaglia G, Dehò F, Salonia A, Briganti A, Montorsi F

机构信息

Division of Oncology, Unit of Urology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy.

出版信息

Ann Oncol. 2022 May;33(5):561. doi: 10.1016/j.annonc.2022.01.075. Epub 2022 Feb 2.

DOI:10.1016/j.annonc.2022.01.075

PMID:35121006

Abstract

摘要

相似文献

Bladder cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.

Ann Oncol. 2022 May;33(5):561. doi: 10.1016/j.annonc.2022.01.075. Epub 2022 Feb 2.

Bladder cancer: ESMO Practice Guidelines for diagnosis, treatment and follow-up.

Ann Oncol. 2014 Sep;25 Suppl 3:iii40-8. doi: 10.1093/annonc/mdu223. Epub 2014 Aug 5.

[S3 guideline for bladder cancer : Claim and reality - a critical commentary from the guideline coordinators].

Urologe A. 2016 Sep;55(9):1188-91. doi: 10.1007/s00120-016-0196-0.

Bladder cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Ann Oncol. 2011 Sep;22 Suppl 6:vi45-9. doi: 10.1093/annonc/mdr376.

Invasive bladder cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.

Ann Oncol. 2009 May;20 Suppl 4:79-80. doi: 10.1093/annonc/mdp136.

[Short version of the German S3 guideline for bladder cancer].

Urologe A. 2016 Sep;55(9):1173-87. doi: 10.1007/s00120-016-0195-1.

Bladder cancer: ESMO Practice Guidelines for diagnosis, treatment and follow-up.

Ann Oncol. 2010 May;21 Suppl 5:v134-6. doi: 10.1093/annonc/mdq175.

Invasive bladder cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.

Ann Oncol. 2008 May;19 Suppl 2:ii47-8. doi: 10.1093/annonc/mdn085.

[CANCER PATIENTS FOLLOW-UP – CROATIAN SOCIETY OF MEDICAL ONCOLOGY CLINICAL GUIDELINES Part II: renal cell cancer, urinary bladder cancer, prostate cancer, testicular cancer].

Lijec Vjesn. 2016 Jul-Aug;138(7-8):167-72.

Management of non-muscle invasive bladder cancer: A comprehensive analysis of guidelines from the United States, Europe and Asia.

Cancer Treat Rev. 2016 Jun;47:22-31. doi: 10.1016/j.ctrv.2016.05.002. Epub 2016 May 10.

引用本文的文献

Severe Rectal Stenosis as the First Clinical Appearance of a Metastasis Originating from the Bladder: A Case Report and Literature Review.

Life (Basel). 2025 Apr 22;15(5):682. doi: 10.3390/life15050682.

Contemporary Trends and Predictors Associated with Adverse Pathological Upstaging Among Non-Metastatic Localized Clinical T2 Muscle-Invasive Bladder Cancers Undergoing Radical Cystectomy: Outcomes from a Single Tertiary Centre in the United Kingdom.

Cancers (Basel). 2025 Apr 27;17(9):1477. doi: 10.3390/cancers17091477.

Bousigonine D from Bousigonia mekongensis inhibits bladder cancer growth and overcomes cisplatin resistance.

Sci Rep. 2025 May 9;15(1):16254. doi: 10.1038/s41598-025-96892-w.

CDCA4 promotes bladder cancer progression by JAK/STAT signaling pathway.

J Cancer Res Clin Oncol. 2025 Jan 24;151(2):46. doi: 10.1007/s00432-025-06109-w.

Effect of Clinical Complete Remission Following Neoadjuvant Pembrolizumab or Chemotherapy in Bladder-Preservation Strategy in Patients with Muscle-Invasive Bladder Cancer Declining Definitive Local Therapy.

Cancers (Basel). 2024 Feb 23;16(5):894. doi: 10.3390/cancers16050894.

A bibliometric insight into neoadjuvant chemotherapy in bladder cancer: trends, collaborations, and future avenues.

Front Immunol. 2024 Feb 19;15:1297542. doi: 10.3389/fimmu.2024.1297542. eCollection 2024.

Hesperetin Inhibits Bladder Cancer Cell Proliferation and Promotes Apoptosis and Cycle Arrest by PI3K/AKT/FoxO3a and ER Stress-mitochondria Pathways.

Curr Med Chem. 2024 Feb 13. doi: 10.2174/0109298673283888231217174702.

The role of the symbiotic microecosystem in cancer: gut microbiota, metabolome, and host immunome.

Front Immunol. 2023 Aug 24;14:1235827. doi: 10.3389/fimmu.2023.1235827. eCollection 2023.

A risk model based on pyroptosis subtypes predicts tumor immune microenvironment and guides chemotherapy and immunotherapy in bladder cancer.

Sci Rep. 2022 Dec 12;12(1):21467. doi: 10.1038/s41598-022-26110-4.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验